Hypothalamic‐Pituitary‐Adrenocortical Axis: Neuropsychiatric Aspects
The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Abstract
Evidence of aberrant hypothalamic-pituitary-adrenocortical (HPA) activity in many psychiatric disorders, although not universal, has sparked long-standing interest in HPA hormones as biomarkers of disease or treatment response. HPA activity may be chronically elevated in melancholic depression, panic disorder, obsessive-compulsive disorder, and schizophrenia. The HPA axis may be more reactive to stress in social anxiety disorder and autism spectrum disorders. In contrast, HPA activity is more likely to be low in PTSD and atypical depression. Antidepressants are widely considered to inhibit HPA activity, although inhibition is not unanimously reported in the literature. There is evidence, also uneven, that the mood stabilizers lithium and carbamazepine have the potential to augment HPA measures, while benzodiazepines, atypical antipsychotics, and to some extent, typical antipsychotics have the potential to inhibit HPA activity. Currently, the most reliable use of HPA measures in most disorders is to predict the likelihood of relapse, although changes in HPA activity have also been proposed to play a role in the clinical benefits of psychiatric treatments. Greater attention to patient heterogeneity and more consistent approaches to assessing treatment effects on HPA function may solidify the value of HPA measures in predicting treatment response or developing novel strategies to manage psychiatric disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sapolsky, R. M., Romero, L. M., & Munck, A. U. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0389 · Cited by 7,541
Sapolsky, R. M. (2000) · Endocrine Reviews · doi:10.1210/er.21.1.55 · Cited by 7,533
Neural regulation of endocrine and autonomic stress responses
Ulrich-Lai, Y. M., & Herman, J. P. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2647 · Cited by 3,318
Brain corticosteroid receptor balance in health and disease
de Kloet, E. R., Vreugdenhil, E., Oitzl, M. S., & Joëls, M. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.3.0331 · Cited by 2,614
Brain corticosteroid receptor balance in health and disease
de Kloet, E. R. (1998) · Endocrine Reviews · doi:10.1210/er.19.3.269 · Cited by 2,614
Gold, P. W., & Chrousos, G. P. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001032 · Cited by 1,274
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment
Pariante, C. M., & Miller, A. H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01088-x · Cited by 1,147
Stetler, C., & Miller, G. E. (2011) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31820ad12b · Cited by 1,123
Meta-Analysis of the Efficacy of Treatments for Posttraumatic Stress Disorder
Watts, B. V., Schnurr, P. P., Mayo, L., Young-Xu, Y., Weeks, W. B., & Friedman, M. J. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12r08225 · Cited by 985
Kessler, R. C. (2012) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2011.11.005 · Cited by 871
Geddes, J. R., & Miklowitz, D. J. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60857-0 · Cited by 848
Depression and Risk of Stroke Morbidity and Mortality: A Meta-analysis and Systematic Review
Pan, A., Sun, Q., Okereke, O. I., Rexrode, K. M., & Hu, F. B. (2011) · JAMA · doi:10.1001/jama.2011.1282 · Cited by 819
Major depressive disorder and hypothalamic-pituitary-adrenal axis activity
Vreeburg, S. A., Hoogendijk, W. J. G., van Pelt, J., DeRijk, R. H., Verhagen, J. C. M., van Dyck, R., Smit, J. H., Zitman, F. G., & Penninx, B. W. J. H. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.50 · Cited by 792
Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder
Rush, A. J., Kraemer, H. C., Sackeim, H. A., Fava, M., Trivedi, M. H., Frank, E., Ninan, P. T., Thase, M. E., Gelenberg, A. J., Kupfer, D. J., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301131 · Cited by 707 · cited 1×
“(339,400), “response” continues to be equated with treatment success.”
The combined dexamethasone/CRH test: A refined laboratory test for psychiatric disorders
Heuser, I., Yassouridis, A., & Holsboer, F. (1994) · Journal of Psychiatric Research · doi:10.1016/0022-3956(94)90017-5 · Cited by 662
Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia
Walker, E., Mittal, V., & Tessner, K. (2008) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.4.022007.141248 · Cited by 615
The Dexamethasone Suppression Test for Diagnosis and Prognosis in Psychiatry: Commentary and Review
Arana, G. W. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790350067012 · Cited by 526
Urinary Free-Cortisol Levels in Posttraumatic Stress Disorder Patients
MASON, J. W., GILLER, E. L., KOSTEN, T. R., OSTROFF, R. B., & PODD, L. (1986) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198603000-00003 · Cited by 455
Prenatal stress and risk for autism
KINNEY, D., MUNIR, K., CROWLEY, D., & MILLER, A. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.06.004 · Cited by 440
Webster, M. J., Knable, M. B., O'Grady, J., Orthmann, J., & Weickert, C. S. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001139 · Cited by 420
Status of Glucocorticoid Alterations in Post‐traumatic Stress Disorder
Yehuda, R. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04979.x · Cited by 409
Impact of Sleep and Its Disturbances on Hypothalamo-Pituitary-Adrenal Axis Activity
Balbo, M., Leproult, R., & Van Cauter, E. (2010) · International Journal of Endocrinology · doi:10.1155/2010/759234 · Cited by 408
Makino, S., Gold, P. W., & Schulkin, J. (1994) · Brain Research · doi:10.1016/0006-8993(94)91862-7 · Cited by 400
Lowry, C. A. (2002) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2002.00861.x · Cited by 362
DST Studies in Psychotic Depression: A Meta-Analysis
Nelson, J. C., & Davis, J. M. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.11.1497 · Cited by 356
Zobel, A. W., Nickel, T., Sonntag, A., Uhr, M., Holsboer, F., & Ising, M. (2001) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(01)00013-9 · Cited by 354
Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder
Watson, S., Gallagher, P., Ritchie, J. C., Ferrier, I. N., & Young, A. H. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.6.496 · Cited by 343
Ising, M., Horstmann, S., Kloiber, S., Lucae, S., Binder, E. B., Kern, N., Künzel, H. E., Pfennig, A., Uhr, M., & Holsboer, F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.039 · Cited by 341 · cited 1×
“Where longitudinal studies have been performed, normalization of HPA activity in both the dexamethasone suppression (172) and dex/CRH tests (185) has been found to occur 2 to 3 weeks before significant clinical improvement, which has raised interest in the possibility, discussed below, that HPA…”
Higher cortisol levels following exposure to traumatic reminders in abuse-related PTSD
Elzinga, B. M., Schmahl, C. G., Vermetten, E., van Dyck, R., & Bremner, J. D. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300226 · Cited by 341
Cytokines and Glucocorticoid Receptor Signaling
Pace, T. W. W., & Miller, A. H. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04984.x · Cited by 339
Shepard, J. D., Barron, K. W., & Myers, D. A. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02019-9 · Cited by 321
Neurochemical correlates of autistic disorder: a review of the literature
Lam, K. S. L., Aman, M. G., & Arnold, L. E. (2006) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2005.03.003 · Cited by 318
Young, A. H., Gallagher, P., Watson, S., Del-Estal, D., Owen, B. M., & Nicol Ferrier, I. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300471 · Cited by 318
The Pharmacologic Treatment of Anxiety Disorders: A Review of Progress
Ravindran, L. N., & Stein, M. B. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10r06218blu · Cited by 317 · cited 1×
“These drugs are approved to treat bipolar depression, although off-label use of anticonvulsants has been tested to treat anxiety disorders (323) and PTSD (436).”
Salivary Cortisol Levels in Persons With and Without Different Anxiety Disorders
Vreeburg, S. A., Zitman, F. G., van Pelt, J., DeRijk, R. H., Verhagen, J. C. M., van Dyck, R., Hoogendijk, W. J. G., Smit, J. H., & Penninx, B. W. J. H. (2010) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181d2f0c8 · Cited by 312
Cognitive dysfunction in depression: Neurocircuitry and new therapeutic strategies
Murrough, J. W., Iacoviello, B., Neumeister, A., Charney, D. S., & Iosifescu, D. V. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.06.006 · Cited by 307 · cited 1×
“In addition, glucocorticoids affect attention and memory retrieval (93) in a manner that could account for some of the cognitive deficits reported in depression and schizophrenia (125, 281).”
Neuroendocrine and Psychophysiologic Responses in PTSD: A Symptom Provocation Study
Liberzon, I. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00128-6 · Cited by 292
Zohar, J., Yahalom, H., Kozlovsky, N., Cwikel-Hamzany, S., Matar, M. A., Kaplan, Z., Yehuda, R., & Cohen, H. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.06.001 · Cited by 292
Gourley, S. L., Wu, F. J., Kiraly, D. D., Ploski, J. E., Kedves, A. T., Duman, R. S., & Taylor, J. R. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.07.016 · Cited by 287
Adrenal Gland Enlargement in Major Depression: A Computed Tomographic Study
Nemeroff, C. B. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820050048008 · Cited by 283
Resistance to Suppression by Dexamethasone of Plasma 11-O.H.C.S. Levels in Severe Depressive Illness
Carroll, B. J., Martin, F. I. R., & Davies, B. (1968) · BMJ · doi:10.1136/bmj.3.5613.285 · Cited by 279
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.4.656 · Cited by 278
Minireview: Stress-related psychiatric disorders with low cortisol levels: A metabolic hypothesis
Yehuda, R., & Seckl, J. (2011) · Endocrinology · doi:10.1210/en.2011-1218 · Cited by 276
Cortisol circadian rhythms and response to stress in children with autism
Corbett, B. A., Mendoza, S., Abdullah, M., Wegelin, J. A., & Levine, S. (2006) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.05.011 · Cited by 258 · cited 2×
“Autistic individuals have been found to exhibit higher salivary cortisol levels after a variety of social and nonsocial stressors, including venipuncture, mock MRI exposure, and public speech and math tests (77,78,381,406).”
Binneman, B., Feltner, D., Kolluri, S., Shi, Y., Qiu, R., & Stiger, T. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07071199 · Cited by 254 · cited 1×
“A second trial with a different non-peptide CRHR1 antagonist was discontinued because initial analysis of depression scores failed to show significant differences in patient response rates from placebo treatment (33).”
Hypothalamic-pituitary-adrenal axis and bipolar disorder
Daban, C., Vieta, E., Mackin, P., & Young, A. H. (2005) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2005.01.005 · Cited by 245
11β-Hydroxysteroid dehydrogenases and the brain: From zero to hero, a decade of progress
Wyrwoll, C. S., Holmes, M. C., & Seckl, J. R. (2011) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2010.12.001 · Cited by 244
Roelofs, K., van Peer, J., Berretty, E., Jong, P. D., Spinhoven, P., & Elzinga, B. M. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.022 · Cited by 236
Ryan, M. C. M., Sharifi, N., Condren, R., & Thakore, J. H. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2003.08.011 · Cited by 225
Enhanced Cortisol Response to Stress in Children in Autism
Spratt, E. G., Nicholas, J. S., Brady, K. T., Carpenter, L. A., Hatcher, C. R., Meekins, K. A., Furlanetto, R. W., & Charles, J. M. (2012) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-011-1214-0 · Cited by 222
Nir, I., Meir, D., Zilber, N., Knobler, H., Hadjez, J., & Lerner, Y. (1995) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02178193 · Cited by 221
Cortisol Circadian Rhythm Alterations in Psychotic Major Depression
Keller, J., Flores, B., Gomez, R. G., Solvason, H. B., Kenna, H., Williams, G. H., & Schatzberg, A. F. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.014 · Cited by 217
Role of CRF Receptor Signaling in Stress Vulnerability, Anxiety, and Depression
Hauger, R. L., Risbrough, V., Oakley, R. H., Olivares‐Reyes, J. A., & Dautzenberg, F. M. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05011.x · Cited by 217
Clinical and Biological Effects of Mifepristone Treatment for Psychotic Depression
Flores, B. H., Kenna, H., Keller, J., Solvason, H. B., & Schatzberg, A. F. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300884 · Cited by 203
An investigation of traumatic life events and obsessive-compulsive disorder
Cromer, K. R., Schmidt, N. B., & Murphy, D. L. (2007) · Behaviour Research and Therapy · doi:10.1016/j.brat.2006.08.018 · Cited by 201
Cell atrophy and loss in depression: reversal by antidepressant treatment
Banasr, M., Dwyer, J. M., & Duman, R. S. (2011) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2011.09.002 · Cited by 201
Kunugi, H., Ida, I., Owashi, T., Kimura, M., Inoue, Y., Nakagawa, S., Yabana, T., Urushibara, T., Kanai, R., Aihara, M., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300868 · Cited by 200
Metyrapone as Additive Treatment in Major Depression: A Double-blind and Placebo-Controlled Trial
Jahn, H., Schick, M., Kiefer, F., Kellner, M., Yassouridis, A., & Wiedemann, K. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.12.1235 · Cited by 184
Responses of “generalized” and “discrete” social phobics during public speaking
Levin, A. P., Saoud, J. B., Strauman, T., Gorman, J. M., Fyer, A. J., Crawford, R., & Liebowitz, M. R. (1993) · Journal of Anxiety Disorders · doi:10.1016/0887-6185(93)90003-4 · Cited by 182
Endocrine withdrawal syndromes
Hochberg, Z., Pacak, K., & Chrousos, G. P. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0014 · Cited by 181
Neural Circuitry in the Regulation of Adrenal Corticosterone Rhythmicity
Engeland, W. C., & Arnhold, M. M. (2005) · Endocrine · doi:10.1385/endo:28:3:325 · Cited by 178
Jansen, L. M. C., Gispen-de Wied, C. C., Wiegant, V. M., Westenberg, H. G. M., Lahuis, B. E., & van Engeland, H. (2006) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0124-z · Cited by 177
Neuroendocrinological mechanisms of actions of antidepressant drugs
Schüle, C. (2007) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2006.01516.x · Cited by 167
Changes in cortisol and DHEA plasma levels after psychotherapy for PTSD
Olff, M., de Vries, G.-J., Güzelcan, Y., Assies, J., & Gersons, B. P. R. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.04.001 · Cited by 159
HPA axis response to a psychological stressor in generalised social phobia
Condren, R. (2002) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(01)00070-1 · Cited by 155
Clinical and Neurobiological Effects of Tianeptine and Paroxetine in Major Depression
Nickel, T., Sonntag, A., Schill, J., Zobel, A. W., Ackl, N., Brunnauer, A., Murck, H., Ising, M., Yassouridis, A., Steiger, A., et al. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200304000-00008 · Cited by 152
Banki, C. M., Karmacsi, L., Bissette, G., & Nemeroff, C. B. (1992) · European Neuropsychopharmacology · doi:10.1016/0924-977x(92)90019-5 · Cited by 149
Watson, S., Gallagher, P., Porter, R. J., Smith, M. S., Herron, L. J., Bulmer, S., Young, A. H., & Ferrier, I. N. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.05.029 · Cited by 145
Serotonin regulates hippocampal glucocorticoid receptor expression via a 5-HT7 receptor
Laplante, P., Diorio, J., & Meaney, M. J. (2002) · Developmental Brain Research · doi:10.1016/s0165-3806(02)00550-3 · Cited by 135
Penninx, B. W. J. H., Beekman, A. T. F., Corsi, A. M., Bremmer, M., Hoogendijk, W. J., Guralnik, J. M., Ferrucci, L., & Bandinelli, S. (2007) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e318033ed80 · Cited by 134
Hypothalamic–pituitary–adrenal axis function in patients with chronic depression
WATSON, S., GALLAGHER, P., DEL-ESTAL, D., HEARN, A., FERRIER, I. N., & YOUNG, A. H. (2002) · Psychological Medicine · doi:10.1017/s0033291702005998 · Cited by 130
Handwerger, K. (2009) · Harvard Review of Psychiatry · doi:10.1080/10673220902996775 · Cited by 122
Fink, G., Robinson, I. C., & Tannahill, L. A. (1988) · The Journal of Physiology · doi:10.1113/jphysiol.1988.sp017165 · Cited by 121 · cited 1×
“Glucocorticoids in turn regulate their own secretion by feedback inhibition, reducing the synthesis and secretion of CRH, vasopressin, and ACTH, but probably not oxytocin (103, 117, 458).”
Relapse of Depression After ECT: A Review
Bourgon, L. N., & Kellner, C. H. (2000) · The Journal of ECT · doi:10.1097/00124509-200003000-00003 · Cited by 118
Muglia, L. J., Jacobson, L., Weninger, S. C., Luedke, C. E., Bae, D. S., Jeong, K. H., & Majzoub, J. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119487 · Cited by 115
Self-citationShepard, J. D., Barron, K. W., & Myers, D. A. (2003) · Brain Research · doi:10.1016/s0006-8993(02)03978-1 · Cited by 110
Coplan, J. D., Goetz, R., Klein, D. F., Papp, L. A., Fyer, A. J., Liebowitz, M. R., Davies, S. O., & Gorman, J. M. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.2.130 · Cited by 96
Xing, G.-Q., Russell, S., Webster, M. J., & Post, R. M. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703004000 · Cited by 91
van Zuiden, M., Heijnen, C. J., Maas, M., Amarouchi, K., Vermetten, E., Geuze, E., & Kavelaars, A. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.03.018 · Cited by 91
Elevated alpha-amylase but not cortisol in generalized social anxiety disorder
van Veen, J. F., van Vliet, I. M., DeRijk, R. H., van Pelt, J., Mertens, B., & Zitman, F. G. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.07.004 · Cited by 88
Corticosterone acts on the brain to inhibit adrenalectomy-induced adrenocorticotropin secretion
LEVIN, N., SHINSAKO, J., & DALLMAN, M. F. (1988) · Endocrinology · doi:10.1210/endo-122-2-694 · Cited by 87 · cited 1×
“By virtue of expressing the higher affinity MR, the brain is a more important site for feedback inhibition by naturally occurring glucocorticoids such as cortisol (238).”
Sex differences in hormonal responses to a social stressor in chronic major depression
Chopra, K. K., Ravindran, A., Kennedy, S. H., Mackenzie, B., Matthews, S., Anisman, H., Bagby, R. M., Farvolden, P., & Levitan, R. D. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.03.014 · Cited by 86
Elevated daytime cortisol levels: a biomarker of subsequent major affective disorder?
Ellenbogen, M. A., Hodgins, S., Linnen, A.-M., & Ostiguy, C. S. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.01.007 · Cited by 80 · cited 1×
“sion by virtue of family history, life stress, or personality type, but who are currently healthy (56, 106, 107).”
The risk of affective disorders in patients with adrenocortical insufficiency
Thomsen, A. F., Kvist, T. K., Andersen, P. K., & Kessing, L. V. (2006) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2006.01.003 · Cited by 79
Nocturnal hormone profiles in patients with schizophrenia treated with olanzapine
Mann, K., Rossbach, W., Müller, M. J., Müller-Siecheneder, F., Pott, T., Linde, I., Dittmann, R. W., & Hiemke, C. (2006) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.08.005 · Cited by 78
Brunelin, J., d'Amato, T., van Os, J., Cochet, A., Suaud-Chagny, M.-F., & Saoud, M. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.11.009 · Cited by 74
Ellenbogen, M. A., Santo, J. B., Linnen, A., Walker, C., & Hodgins, S. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00770.x · Cited by 72
Kaneko, M., Yokoyama, F., Hoshino, Y., Takahagi, K., Murata, S., Watanabe, M., & Kumashiro, H. (2008) · Neuropsychobiology · doi:10.1159/000118800 · Cited by 70 · cited 3×
“Where HPA hyperactivity or dexamethasone nonsuppression was observed, it was difficult to relate to negative (withdrawal) or positive (hallucination) symptoms, although there may be a better correlation with negative symptoms in long-standing schizophrenia (39,202,369,461).”
Gola, H., Engler, H., Schauer, M., Adenauer, H., Riether, C., Kolassa, S., Elbert, T., & Kolassa, I.-T. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.06.005 · Cited by 64
VIETA, E., MARTÍNEZ-DE-OSABA, M. J., COLOM, F., MARTÍNEZ-ARÁN, A., BENABARRE, A., & GASTÓ, C. (1999) · Psychological Medicine · doi:10.1017/s0033291799008727 · Cited by 62
The significance of HPA axis disturbance in panic disorder
Coryell, W., Noyes, R., & Schlechte, J. (1989) · Biological Psychiatry · doi:10.1016/0006-3223(89)90287-4 · Cited by 47
Yau, J. L. W., Noble, J., Thomas, S., Kerwin, R., Morgan, P. E., Lightman, S., Seckl, J. R., & Pariante, C. M. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301389 · Cited by 46
Valiengo, L. L., Soeiro-de-Souza, M. G., Marques, A. H., Moreno, D. H., Juruena, M. F., Andreazza, A. C., Gattaz, W. F., & Machado-Vieira, R. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.11.046 · Cited by 36
Heiske, A., Jesberg, J., Krieg, J.-C., & Vedder, H. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300056 · Cited by 35
Spijker, A. T., Giltay, E. J., van Rossum, E. F. C., Manenschijn, L., DeRijk, R. H., Haffmans, J., Zitman, F. G., & Hoencamp, E. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.03.020 · Cited by 30
Oxcarbazepine accelerates cortisol elimination via cytochrome P450 3A4 induction
Hogler, W., Wudy, S. A., Luef, G., Hartmann, M. F., & Rauchenzauner, M. (2010) · Archives of Disease in Childhood · doi:10.1136/adc.2009.167361 · Cited by 25
Bschor, T., Ritter, D., Winkelmann, P., Erbe, S., Uhr, M., Ising, M., & Lewitzka, U. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027613 · Cited by 23
Cited by
Huo, R., Zeng, B., Zeng, L., Cheng, K., Li, B., Luo, Y., Wang, H., Zhou, C., Fang, L., Li, W., et al. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00489 · Cited by 221
Hao, Y.-H., Fountain, M. D., Fon Tacer, K., Xia, F., Bi, W., Kang, S.-H. L., Patel, A., Rosenfeld, J. A., Le Caignec, C., Isidor, B., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.033 · Cited by 206
Stress and functional neurological disorders: mechanistic insights
Keynejad, R. C., Frodl, T., Kanaan, R., Pariante, C., Reuber, M., & Nicholson, T. R. (2019) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-318297 · Cited by 151
Findling, J. W., & Raff, H. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0946 · Cited by 134
Atypical Lateralization in Neurodevelopmental and Psychiatric Disorders: What Is the Role of Stress?
Berretz, G., Wolf, O. T., Güntürkün, O., & Ocklenburg, S. (2020) · Cortex · doi:10.1016/j.cortex.2019.12.019 · Cited by 100
Metadata
- Authors
- Jacobson, L.
- Venue
- Comprehensive Physiology
- Publisher
- Wiley
- Published
- 2014-03-19
- Volume
- 4
- Issue
- 2
- Pages
- 715-738
- ISSN
- 2040-4603 (ISSN-L)
- OpenAlex
- W1564761480
- Cited by
- 144
- References
- 97
- Type
- other
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.